132 related articles for article (PubMed ID: 5695780)
21. [Evolution of immunoglobulins IgA, IgM, IgG and LATS during treatment of hyperthyroidism with carmibazole and radioiodine].
Mahaux JE; Delcourt R; Nagel M; Chamla-Soumenkoff J; Levin S
Ann Endocrinol (Paris); 1970; 31(2):314-23. PubMed ID: 4192759
[No Abstract] [Full Text] [Related]
22. PRESENCE OF THE LONG-ACTING THYROID STIMULATOR IN SERUM IN MONGOLISM WITHOUT HYPERTHYROIDISM.
MOSIER HD
J Clin Endocrinol Metab; 1965 Aug; 25():1005-8. PubMed ID: 14328369
[No Abstract] [Full Text] [Related]
23. [Effect of iodine administration on the thyrotropic hormone and long-acting thyroid stimulator level in the plasma].
Földes J; Krasznai I; Piroska E; Gesztesi E; Takács I
Endokrinologie; 1967; 52(1):80-7. PubMed ID: 4171706
[No Abstract] [Full Text] [Related]
24. [The long acting thyroid stimulator (LATS) in some thyroid diseases. Preliminary results].
Busnardo B; Accordi F; Debiasi S
Acta Isot (Padova); 1968 Oct; 8(2):165-79. PubMed ID: 5761578
[No Abstract] [Full Text] [Related]
25. Occurrence in thyrotoxicosis of a gamma globulin which protects LATS from neutralization by an extract of thyroid gland.
Adams DD; Kennedy TH
J Clin Endocrinol Metab; 1967 Feb; 27(2):173-7. PubMed ID: 4163610
[No Abstract] [Full Text] [Related]
26. [Chronic thrombopenic purpura. Hyperthyroidism, pretibial myxedema and L.A.T.S].
Cattan D; Caen J; Fernandez Y; Izard J; Leclere H; Tanguy A; Lemenager J
Presse Med (1893); 1970 Jul; 78(35):1535-40. PubMed ID: 5464336
[No Abstract] [Full Text] [Related]
27. The role of surgery and 131-I therapy for hyperthyroidism in the etiology of thyroid carcinoma.
Ashkar FS; Miale A; Smoak WM; Weinstein MB
South Med J; 1973 Sep; 66(9):1014-6. PubMed ID: 4733573
[No Abstract] [Full Text] [Related]
28. ["Long-acting thyroid stimulator" and thyrotropic hormone in thyrotoxicosis in newborn infants].
Gautier E; Juillard E; Lemarchand-Béraud T
Schweiz Med Wochenschr; 1968 Jan; 98(1):8-12. PubMed ID: 5695264
[No Abstract] [Full Text] [Related]
29. Studies of serum long-acting thyroid stimulator (LATS) in relation to exophthalmos after therapy for thyrotoxicosis.
Hetzel BS; Mason EK; Wang HK
Australas Ann Med; 1968 Nov; 17(4):307-11. PubMed ID: 4178378
[No Abstract] [Full Text] [Related]
30. DIAGNOSIS AND NON-OPERATIVE TREATMENT OF THYROTOXICOSIS.
HALES I
J Coll Radiol Australas; 1964 Jun; 8():98-103. PubMed ID: 14173986
[No Abstract] [Full Text] [Related]
31. EFFECT OF TREATMENT OF THYROTOXICOSIS ON EXOPHTHALMOS.
GREIG WR; ABOUL-KHAIR SA; MOHAMED SD; CROOKS J
Br Med J; 1965 Aug; 2(5460):509-10. PubMed ID: 14321223
[No Abstract] [Full Text] [Related]
32. Triiodothyronine levels in patients with euthyroid endocrine exophthalmos and during treatment of thyrotoxicosis.
Hesch RD; Huefner M; zur Mühlen A von ; Emrich D
Acta Endocrinol (Copenh); 1974 Mar; 75(3):514-22. PubMed ID: 4131145
[No Abstract] [Full Text] [Related]
33. The pathogenesis of thyrotoxicosis the discovery of LATS.
Adams DD
N Z Med J; 1975 Jan; 81(531):15-7. PubMed ID: 1055308
[No Abstract] [Full Text] [Related]
34. THYROTROPIN AND LONG-ACTING THYROID STIMULATOR ASSAYS IN THYROID DISEASE.
PINCHERA A; PINCHERA MG; STANBURY JB
J Clin Endocrinol Metab; 1965 Feb; 25():189-208. PubMed ID: 14264241
[No Abstract] [Full Text] [Related]
35. Radioiodine therapy of thyrotoxicosis.
Jackson GL
Am J Roentgenol Radium Ther Nucl Med; 1971 Aug; 112(4):726-31. PubMed ID: 5562738
[No Abstract] [Full Text] [Related]
36. Observations on the therapeutic merit of thyroid radioablation for treatment of malignant exophthalmos.
Weiss ER; Blahd WH; Winston MA; Krishnamurthy GT
Nucl Med (Stuttg); 1972 Nov; 11(3):226-33. PubMed ID: 4678769
[No Abstract] [Full Text] [Related]
37. Effect of thyroid ablation on dysthyroid exophthalmos.
Boyle IT; Greig WR; Thomson JA; Winning J; McGirr EM
Proc R Soc Med; 1969 Jan; 62(1):19-23. PubMed ID: 5818232
[No Abstract] [Full Text] [Related]
38. EVIDENCE OF A NORMALLY FUNCTIONING PITUITARY TSH SECRETION MECHANISM IN A PATIENT WITH A HIGH BLOOD LEVEL OF LONG-ACTING THYROID STIMULATOR.
ADAMS DD; KENNEDY TH
J Clin Endocrinol Metab; 1965 May; 25():571-6. PubMed ID: 14313750
[No Abstract] [Full Text] [Related]
39. [Para-neoplastic hyperthyroidism with elevated plasmatic T.S.H].
Codaccioni JL; Jaquet P
Ann Endocrinol (Paris); 1971; 52(4):553-6. PubMed ID: 5139434
[No Abstract] [Full Text] [Related]
40. Non-specific responses in the assay of thyrotrophin and long-acting thyroid stimulator.
Adams DD; Kennedy TH; Purves HD
Aust J Exp Biol Med Sci; 1966 Aug; 44(4):355-64. PubMed ID: 5967342
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
